Related Experiment Video
Updated: Jul 9, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Oxidative Stress-regulating Enzymes and Endometrial Cancer Survival in Relation to Metformin Intake in Diabetic
Ewelina Kuusiniemi1,2,3, Peeter Karihtala4, Ulla Puistola5,2,3
1Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland; ewelina.kuusiniemi@gmail.com.
Background/Aim:
Metformin inhibits tumorigenesis in endometrial carcinoma and interferes with the expression of oxidative stress-regulating proteins, such as nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1). Although manganese superoxide dismutase (MnSOD) is vital for withstanding mitochondrial oxidative stress, it has also been linked with chemoresistance and poorer outcomes in several cancer types. However, data on endometrial cancers are limited. This study aimed to highlight the relationship between mitochondrial redox regulation and endometrial cancer survival in relation to metformin consumption in women with type 2 diabetes mellitus (T2DM).
Patients And Methods:
Our retrospective hospital-based cohort study included 121 patients diagnosed with endometrial carcinoma and T2DM between 2007 and 2014. Fifty-eight patients were using metformin at the time of diagnosis. Nrf2 and Keap1 expression levels in the tumor samples were assessed immunohistochemically, and MnSOD levels were measured both immunohistochemically and from the serum samples.
Results:
High MnSOD tissue expression was associated with better overall survival among metformin users in the univariate analysis (p=0.03). When adjusted for histology and stage, high serum MnSOD was associated with better overall survival (HR=0.22, 95%CI=0.07-0.71, p=0.01). No association was found between MnSOD, Nrf2, or Keap1 and overall survival among metformin non-users.
Conclusion:
Higher expression of MnSOD in patients with endometrial cancer and T2DM is associated with better overall survival if the patient is consuming metformin.
Insights
Metformin use in women with type 2 diabetes and endometrial cancer is linked to better survival. Higher manganese superoxide dismutase (MnSOD) levels correlate with improved outcomes in these patients.
Area of Science:
- Oncology
- Metabolism
- Mitochondrial Biology
Background:
- Metformin influences endometrial cancer by affecting oxidative stress proteins like Nrf2 and Keap1.
- Manganese superoxide dismutase (MnSOD) is crucial for managing mitochondrial oxidative stress but has complex roles in cancer.
- Limited data exist on MnSOD's role in endometrial cancer, particularly concerning metformin use.
Purpose of the Study:
- To investigate the association between mitochondrial redox regulation and endometrial cancer survival.
- To explore the impact of metformin consumption on this relationship in women with type 2 diabetes mellitus (T2DM).
Main Methods:
- Retrospective cohort study of 121 endometrial cancer patients with T2DM (2007-2014).
- 58 patients used metformin at diagnosis.
- Assessed tumor Nrf2, Keap1 (immunohistochemistry), and MnSOD (immunohistochemistry and serum).
Main Results:
- High MnSOD tissue expression correlated with better overall survival in metformin users (univariate, p=0.03).
- High serum MnSOD was linked to better overall survival after adjusting for histology and stage (HR=0.22, p=0.01).
- No significant association between MnSOD, Nrf2, or Keap1 and survival was observed in non-metformin users.
Conclusions:
- Elevated MnSOD expression is associated with improved overall survival in endometrial cancer patients with T2DM who are taking metformin.
- This suggests a potential role for MnSOD as a predictive biomarker in metformin-treated endometrial cancer patients.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Psychoneuroimmunology: Diabetes and Cancer
Oogenesis

